PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Global soft contact lens market • Global RGP contact lens market • Global hybrid contact lens market • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Growing initiatives promoting safe usage of contact lenses • Technological advances • Increased preference toward cosmetic contact lens PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Johnson & Johnson • Novartis • The The Cooper Companies Companies • Valeant Pharmaceuticals • ZEISS PART 15: APPENDIX • List of abbreviations Exhibit 01: Parent market Exhibit 02: Global vision care market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global contact lens market 2017-2022 ($ mn) Exhibit 09: Global contact lens market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Product – Market share 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Soft contact lens – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Soft lens – Year-over-year growth 2018-2022 (%) Exhibit 22: RGP lens – Market size and forecast 2017-2022 ($ mn) Exhibit 23: RGP lens – Year-over-year growth 2018-2022 (%) Exhibit 24: Hybrid lens – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Hybrid lens – Year-over-year growth 2018-2022 (%) Exhibit 26: Market opportunity by product Exhibit 27: Customer landscape Exhibit 28: Global – Market share by geography 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Americas – Year-over-year growth 2018-2022 (%) Exhibit 32: Top three countries in Americas Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 35: Top three countries in EMEA Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 37: APAC – Year-over-year growth 2018-2022 (%) Exhibit 38: Top three countries in APAC Exhibit 39: Market opportunity Exhibit 40: Rise in population aged 65 and above (% of total) Exhibit 41: R&D funding for eye disease and disorders of vision for FY 2013 to FY 2016 ($ millions) Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Johnson & Johnson: Overview Exhibit 48: Johnson & Johnson– Business segments Exhibit 49: Johnson & Johnson – Organizational developments Exhibit 50: Johnson & Johnson – Geographic focus Exhibit 51: Johnson & Johnson – Segment focus Exhibit 52: Johnson & Johnson – Key offerings Exhibit 53: Novartis: Overview Exhibit 54: Novartis– Business segments Exhibit 55: Novartis– Organizational developments Exhibit 56: Novartis– Geographic focus Exhibit 57: Novartis– Segment focus Exhibit 58: Novartis– Key offerings Exhibit 59: The Cooper Companies: Overview Exhibit 60: The Cooper Companies– Business segments Exhibit 61: The Cooper Companies– Organizational developments Exhibit 62: The Cooper Companies– Geographic focus Exhibit 63: The Cooper Companies– Segment focus Exhibit 64: The Cooper Companies– Key offerings Exhibit 65: Valeant Pharmaceuticals: Overview Exhibit 66: Valeant Pharmaceuticals– Business segments Exhibit 67: Valeant Pharmaceuticals– Organizational developments Exhibit 68: Valeant Pharmaceuticals– Geographic focus Exhibit 69: Valeant Pharmaceuticals– Segment focus Exhibit 70: Valeant Pharmaceuticals– Key offerings Exhibit 71: ZEISS: overview Exhibit 72: ZEISS– Business segments Exhibit 73: ZEISS– Organizational developments Exhibit 74: ZEISS– Geographic focus Exhibit 75: ZEISS– Segment focus Exhibit 76: ZEISS – Key offerings

Johnson & Johnson Novartis The Cooper Companies Valeant Pharmaceuticals ZEISS